AC Immune (ACIU) vs X4 Pharmaceuticals, Inc. (XFOR)
- AC Immune ACIU 2.39 −2.45%
- X4 Pharmaceuticals, Inc. XFOR 2.59 −1.89%
AC Immune and X4 Pharmaceuticals, Inc. are both Biotechnology companies. AC Immune and X4 Pharmaceuticals, Inc. are of similar size ($261.8M and $249.4M). X4 Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −51.7% against −85.6%. X4 Pharmaceuticals, Inc. has the higher net margin (−568.8% vs −1,783.7%) and the lower return on invested capital (−226.6% vs 0.00%). Across the 17 metrics below, X4 Pharmaceuticals, Inc. leads on 9 and AC Immune on 8.
Valuation
Profitability
| Metric | ACIU | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 81.51% | 65.16% |
| Operating margin | (1,745.75%) | (554.71%) | 0.00% |
| Net margin | (1,783.66%) | (568.80%) | 0.00% |
| Free cash flow margin | 0.00% | (559.95%) | 0.00% |
| Return on equity | 0.00% | (113.08%) | (56.36%) |
| Return on assets | 0.00% | (50.32%) | (48.04%) |
| Return on invested capital | 0.00% | (226.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack